CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 35 enrolled
Drug / intervention
employment-based reinforcementcombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00684788
NCT00684788Phase 2Completed
CompareCT.gov

Employment-Based Depot Naltrexone Clinical Trial

Johns Hopkins University·interventional·Posted May 28, 2008·Updated Dec 26, 2017

In Brief

A Phase 2 clinical trial evaluating employment-based reinforcement for Opiate Dependence. Completed, enrolled 35 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether employment-based naltrexone treatment proves effective in promoting depot naltrexone adherence and drug abstinence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpiate Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 28, 2008
Enrollment StartMay 1, 2006
Primary CompletionMay 1, 2009
Study CompletionMay 3, 2009
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 18.1 years ago

Interventions

employment-based reinforcementcombination

Participants in the "Work Plus Naltrexone Contingency" condition were required to take scheduled doses of depot naltrexone to work and earn wages.